Skip to main content
. Author manuscript; available in PMC: 2013 May 15.
Published in final edited form as: Cancer Res. 2012 Mar 29;72(10):2622–2633. doi: 10.1158/0008-5472.CAN-11-3605

Fig. 6.

Fig. 6

Enhancement of ADI-PEG20's antitumor activity by Ly294002 in the tumor xenografts. (A) Inhibition of tumor growth in the ADI-PEG20-, Ly294002-, and combination of ADI-PEG20+Ly294002-treated group as compared with the PBS-treated group; and (B) representative tumor sizes in animals from the four different treated groups.